Table 4 Disease-modifying antirheumatic drug and prednisone use in the early synovitis patients at initial visit and year-1 follow up
Patient group | DMARD at initial visit | DMARD at year 1 follow-up | Prednisone at initial visit | Prednisone at year 1 follow-up |
|---|---|---|---|---|
RF+ RA | 28/69 (41%) | 46/67 (86%) | 25/69 (36%) | 25/67 (37%) |
RF- RA | 14/36 (39%) | 27/34 (79%) | 16/36 (44%) | 17/36 (50%) |
SpA | 8/43 (19%) | 10/37 (29%) | 11/43 (26%) | 3/37 (8%) |
UA | 11/90 (12%) | 18/79 (23%) | 10/90 (11%) | 9/79 (23%) |